Completed PHASE3 INTERVENTIONAL 4-arm NCT00931645

Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia (Auto-LLC 2001)

Randomized Phase III Trial Evaluating the Role of Autologous Stem Cell Transplantation in Previously Untreated Patients With Stage B and C Chronic Lymphocytic Leukemia

Sponsor: Direction Générale de la Santé, France

Conditions Chronic Lymphocytic Leukemia

Interventions Autologous stem cell transplantation DHAP rescue and Autologous stem cell transplantation DHAP rescue and F+C

Updated 5 times since 2017 Last updated: Jul 1, 2009 Started: Apr 30, 2001 Primary completion: Dec 31, 2007 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Lymphocytic Leukemia, this trial is completed. The trial is conducted by Direction Générale de la Santé, France and has accumulated 5 data snapshots since 2001. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Direction Générale de la Santé, France
University Hospital, Caen

Data source: University Hospital, Caen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France